Differential impact of osteoporosis, sarcopenia and obesity on physical performance in aging men.

obesity osteoporosis physical performance sarcopenia

Journal

Endocrine connections
ISSN: 2049-3614
Titre abrégé: Endocr Connect
Pays: England
ID NLM: 101598413

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 04 01 2021
accepted: 18 01 2021
pubmed: 22 1 2021
medline: 22 1 2021
entrez: 21 1 2021
Statut: ppublish

Résumé

Aging and concurrent constitutional changes as sarcopenia, osteoporosis and obesity are associated with progressive functional decline. Coincidence and mutual interference of this risk factors require further evaluation. Cross-sectional evaluation of musculoskeletal health in a community-dwelling cohort of men aged 65-90 years. Objectives included descriptive analysis of age-related decline in physical performance, prevalence of osteoporosis (FRAX-Score), sarcopenia (EWGSOP criteria) and obesity (BMI > 30 kg/m2) and their coincidence/interference. Based on 507 participants assessed, aging was associated with progressive functional deterioration, regarding power (chair rise test -1.54% per year), performance (usual gait speed -1.38% per year) and muscle force (grip strength -1.52% per year) while muscle mass declined only marginally (skeletal muscle index -0.29% per year). Prevalence of osteoporosis was 41.8% (n = 212) while only 22.9% (n = 116) of the participants met the criteria for sarcopenia and 23.7% (n = 120) were obese. Osteosarcopenia was found in n = 79 (15.6%), sarcopenic obesity was present in 14 men (2.8%). A combination of all three conditions could be confirmed in n = 8 (1.6%). There was an inverse correlation of BMI with physical performance whereas osteoporosis and sarcopenia did not interfere with functional outcomes. Based on current definitions, there is considerable overlap in the prevalence of osteoporosis and sarcopenia, while obesity appears to be a distinct problem. Functional decline appears to be associated with obesity rather than osteoporosis or sarcopenia. It remains to be determined to what extend obesity itself causes performance deficits or if obesity is merely an indicator of insufficient activity eventually predisposing to functional decline.

Identifiants

pubmed: 33475529
doi: 10.1530/EC-20-0580
pii: EC-20-0580.R1
pmc: PMC8052579
doi:
pii:

Types de publication

Journal Article

Langues

eng

Pagination

256-264

Références

J Am Geriatr Soc. 2001 Apr;49(4):398-403
pubmed: 11347782
Am J Epidemiol. 2004 Feb 15;159(4):413-21
pubmed: 14769646
Curr Opin Rheumatol. 2015 Jul;27(4):414-9
pubmed: 26002034
J Bone Miner Res. 2015 Jul;30(7):1301-8
pubmed: 25565555
J Clin Densitom. 2009 Oct-Dec;12(4):413-6
pubmed: 19733110
Osteoporos Int. 2013 May;24(5):1689-96
pubmed: 23212281
Ann Intern Med. 2010 Mar 16;152(6):380-90
pubmed: 20231569
Arch Gerontol Geriatr. 2012 Sep-Oct;55(2):e48-52
pubmed: 22647380
Adv Nutr. 2017 Sep 15;8(5):728-738
pubmed: 28916573
J Am Geriatr Soc. 2010 Nov;58(11):2055-62
pubmed: 21054284
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):129-133
pubmed: 21475695
J Cachexia Sarcopenia Muscle. 2021 Feb;12(1):39-51
pubmed: 33377299
Osteoporos Int. 2010 Apr;21(4):543-59
pubmed: 19779761
Osteoporos Int. 2017 Oct;28(10):2747-2757
pubmed: 28702682
Front Endocrinol (Lausanne). 2020 Jan 14;10:861
pubmed: 31993018
J Bone Miner Res. 2017 Mar;32(3):575-583
pubmed: 27736026
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Am J Mens Health. 2019 Mar-Apr;13(2):1557988319841934
pubmed: 30939990
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):693-700
pubmed: 18827572
J Am Med Dir Assoc. 2016 Oct 1;17(10):960.e1-7
pubmed: 27567461
J Bone Miner Res. 2010 Mar;25(3):513-9
pubmed: 20422623
J Bone Miner Res. 2012 Jan;27(1):1-10
pubmed: 23348758
J Bone Miner Metab. 2007;25(4):237-42
pubmed: 17593494
Dyn Med. 2008 Feb 27;7:4
pubmed: 18304350
Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):71-4
pubmed: 20207030
Calcif Tissue Int. 2019 Aug;105(2):109-124
pubmed: 31098729
Calcif Tissue Int. 2020 Jun;106(6):616-624
pubmed: 32125471
Am J Clin Nutr. 2017 Jul;106(1):130-135
pubmed: 28566307
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):609-618
pubmed: 32202056
Bone. 2015 Aug;77:107-14
pubmed: 25916552
Bull World Health Organ. 2003;81(9):646-56
pubmed: 14710506
Clin Nutr. 2012 Oct;31(5):652-8
pubmed: 22414775
J Appl Physiol (1985). 2000 Aug;89(2):465-71
pubmed: 10926627
J Am Geriatr Soc. 2015 Sep;63(9):1733-40
pubmed: 26310882
Aging Med (Milton). 2019 Sep 08;2(3):147-156
pubmed: 31942528
J Clin Endocrinol Metab. 2009 Sep;94(9):3387-93
pubmed: 19531595
J Bone Miner Res. 2011 Mar;26(3):496-502
pubmed: 20814955
J Am Med Dir Assoc. 2014 Aug;15(8):551-8
pubmed: 24703927

Auteurs

Franca Genest (F)

Clinical Trial Unit, Orthopedic Department, University of Wuerzburg, Wuerzburg, Germany.

Michael Schneider (M)

Clinical Trial Unit, Orthopedic Department, University of Wuerzburg, Wuerzburg, Germany.

Andreas Zehnder (A)

Clinical Trial Unit, Orthopedic Department, University of Wuerzburg, Wuerzburg, Germany.

Dominik Lieberoth-Leden (D)

Clinical Trial Unit, Orthopedic Department, University of Wuerzburg, Wuerzburg, Germany.

Lothar Seefried (L)

Clinical Trial Unit, Orthopedic Department, University of Wuerzburg, Wuerzburg, Germany.

Classifications MeSH